Lung Ultrasound for Guiding Antibiotic Use in Pediatric Pneumonia
A legfontosabb adatok
- Ki végzi
- Meyer Children's Hospital IRCCS
- Hol
- Madison, New Haven, New York és San Diego (Egyesült Államok)Mind a 4 helyszín megnézéseMég 2 másik országban, 14 helyszínen
- Azonosító
- Állapot
- Toboroz
- Résztvevők
- 659 fő, tervezett
- Kezdés
- 2025. ápr. 24.
- Várható befejezés
- 2028. jún. 30.
- A vizsgálat típusa
- Beavatkozással járó, 2 csoportAz egyik csoport nem kap vizsgálati kezelést, összehasonlításként.
- A vizsgált kezelések
- LUNG ULTRASOUND
- A regiszteradat frissítve
- 2026. április 3.
Ki vehet részt
- Életkor
- 3 év – 10 év
- Nem
- Nők és férfiak
- Egészséges önkéntesek
- Nem vehetnek részt
A regiszter feltételei, szó szerint
Mind a 3 feltétel megnézéseKevesebb
Ki vehet részt
- Well-appearing, clinically stable patients aged 3 to 10 years, presenting to the pediatric ED with suspected pneumonia based on a combination of signs and symptoms suggestive of lower respiratory tract infection (LRTI), including:; Respiratory Symptoms: Cough, Tachypnea, Dyspnea (Increased work of breathing), Abnormal findings on auscultation; Systemic Symptoms: Fever, Hypoxia, Decreased appetite
Ki nem vehet részt
- Children aged 3 to 10 years with any of the following factors:; Recent hospitalization (within the past 14 days); Prior CXR or any other chest imaging (e.g. CT scan); Ongoing antibiotic therapy; Hemodynamic instability; Respiratory failure or severe respiratory distress and/or hypoxemia, requiring urgent assessment for conditions such as pneumothorax, hemothorax, or other emergency respiratory conditions; History of aspiration or ab ingestis pneumonia; Underlying medical conditions predisposing to severe or recurrent pneumonia, including immunodeficiency, chronic corticosteroid use, chronic lung disease, malignancy, sickle cell disease, congenital heart disease, tracheostomy, and neuromuscular disorders affecting respiration
- Neonates and children up to 3 years of age, and children older than 10 years
A fő feltételek kérdésként
Magadról válaszolj. Ez nem döntés: hogy részt vehetsz-e, azt csak a vizsgálat csapata mondhatja meg.
- 3 és 10 év között vagy?
Ez a vizsgálat jelenleg itt érhető el: Egyesült Államok.
Még 2 másik országban, 14 helyszínen
- University of WisconsinMadison, Egyesült ÁllamokContact: Niccolò Parri, MDNo longer taking part
- Yale-New Haven Children's HospitalNew Haven, Egyesült ÁllamokContact: Niccolò Parri, MDRésztvevőt keres
- Columbia UniversityNew York, Egyesült ÁllamokContact: Niccolò Parri, MDToborzás még nem indult
- Rady Childrens/UCSDSan Diego, Egyesült ÁllamokContact: Niccolò Parri, MDNo longer taking part
A vizsgálatról
Mit akar kideríteni a vizsgálat
Pneumonia is a major cause of illness and death in children, with an annual incidence of about 3.3 per 1,000 in those under five years old, many requiring hospitalization. The diagnosis is challenging due to the absence of a universally accepted gold standard, leading to variability in emergency settings. Current guidelines recommend diagnosis based on history and physical examination, which do not reliably differentiate pneumonia from other respiratory infections or identify whether it is bacterial or viral in nature. This uncertainty can lead to the unnecessary use of antibiotics.
A teljes eredeti leírásKevesebb
Commonly used chest X-rays have limitations such as low sensitivity, moderate interobserver reliability, and the inability to distinguish bacterial from viral pneumonia. In contrast, lung ultrasound has shown high sensitivity and specificity for diagnosing pneumonia in children. However, lung ultrasound also cannot reliably distinguish between bacterial and viral causes and might lead to increased antibiotic prescriptions by detecting minor lung consolidations not seen on chest X-rays. Despite these issues, lung ultrasound is widely used in pediatric pulmonary assessment.
The primary objective of the study is to determine if using lung ultrasound for diagnosing pneumonia in children can reduce antibiotic prescriptions compared to the standard care approach-which mainly relies on clinical diagnosis (often supplemented by chest X-ray and blood tests in selected cases). The secondary objective is to assess how frequently lung ultrasound impacts management decisions during a single clinical visit, beyond the information provided by history and physical examination. The third objective is to compare the diagnostic accuracy of lung ultrasound-supported diagnosis with existing diagnostic methods.
The study hypothesizes that lung ultrasound results can act as a decision modifier, similar to other clinical tools and examination findings. However, a lack of consensus on specific lung ultrasound parameters and their clinical correlations contributes to variability in managing suspected pneumonia, potentially leading to antibiotic overuse.
Eligible participants are children aged three to ten years who are in good general condition and clinically stable, presenting with signs and symptoms of lower respiratory tract infection indicative of pneumonia. Exclusion criteria include children outside the specified age range, those recently hospitalized, those who have undergone prior chest imaging, those already on antibiotic therapy, those with severe clinical instability, and those with underlying conditions predisposing them to severe or recurrent pneumonia. These criteria help ensure that the study population represents general pediatric community-acquired pneumonia cases, avoiding biases from high-risk patients.
The ultimate goal of this study is to provide evidence on whether lung ultrasound can serve as a reliable tool to guide antibiotic prescriptions, thereby reducing unnecessary antibiotic use in the management of pediatric pneumonia.
A vizsgálat 2 csoportja
- Control group - standard of careNincs vizsgálati kezelés, összehasonlításként
All subjects randomly assigned to the control arm will undergo a complete patient history and clinical assessment (the reference standard). If there is clinical uncertainty, the enrolling physician has the option to perform other test such as CXR or blood test.
- Experimental Group - Lung Ultrasound (LUS)A vizsgált kezelés
All subjects randomly assigned to the investigational arm will undergo lung ultrasound (LUS) . The LUS will be performed immediately following a thorough patient history and complete clinical assessment. Ultrasound still images and ultrasound clips will be acquired according to the study protocol. Detailed methodology of the ultrasound examination and parameters is provided as appendix to the study protocol
Kezelés: LUNG ULTRASOUND
Kérdések a vizsgálat csapatának
- Milyen gyakran kell bejárnom, és egy-egy alkalom mennyi ideig tart?
- Megtérítik az utazási költséget?
- Megtarthatom a saját orvosomat?
- Mi történik, ha ki akarok lépni?
Contact the study team: see the registry record → Contacts and Locations
Oldal nyomtatása az orvosomnakAdatok és források
- Regiszteradat
- Szerepel a ClinicalTrials.gov-on.
- Hivatalos cím
- Lung Ultrasound for Antibiotic Stewardship in Community-Acquired Pneumonia: A Randomized Clinical Trial
- Kérdések a feltételekről
- Forrás: NCT06921993: ki vehet részt
- A regiszteradat frissítve
- 2026. április 3.